Partnerships are integral to Hikma’s strategy. We remain focused on building an increasingly diverse specialty portfolio through acquisition and partnership, including licensing of NDA/ANDA, generic medicines and biosimilars to help put better health within reach, every day across our regions.
Also, we offer contract manufacturing capabilities leveraging the quality, reliability and flexibility of our manufacturing facilities. We operate 32 manufacturing plants across the US, Europe and the MENA region.
Allergic Rhinitis (AR)
Anti-Infectives and Immunosuppressants
Bio-Thera Solutions, Ltd.
Biological, Oncology and Rheumatology
Central Nervous System
Allergic Rhinitis and Urticaria
Gedeon Richter Plc.
Osteoporosis and Fractures
Seasonal allergic rhinitis
Blood Forming and Rare Diseases
Blood and Blood Forming and Cardiovascular
Fusion Protein Therapeutics
Cardiovascular, Gastrointestinal and Musco-Skeletal
Blood and Blood-Forming and Anti-Anemic
Last reviewed on 30 May 2022